Circadian Disruption in Neurodegeneration
Introduction
Circadian rhythm disruption is increasingly recognized as both a consequence and contributor to neurodegenerative diseases. The suprachiasmatic nucleus (SCN) coordinates daily rhythms throughout the body, and its dysfunction affects sleep, metabolism, and neuronal health. Sleep-wake disturbances are among the earliest and most common symptoms of Alzheimer's disease (AD) and Parkinson's disease (PD), often appearing years before clinical diagnosis.
The circadian system is a fundamental biological oscillator that organizes physiology and behavior around the 24-hour day. In neurodegenerative diseases, this temporal organization breaks down at multiple levels—from cellular molecular clocks to systemic hormonal rhythms—creating a vicious cycle that accelerates neuronal dysfunction. [@musiek2016]
Overview
The circadian system regulates: [@walker2017]
- Sleep-wake cycles and arousal states
- Hormone secretion (cortisol, melatonin, growth hormone)
- Body temperature fluctuations
- Metabolic processes and nutrient sensing
- Cognitive function and attention
- Autonomic nervous system activity
The master clock is the suprachiasmatic nucleus (SCN), a small hypothalamic structure containing approximately 20,000 neurons that receives direct light input from the retina via the retinohypothalamic tract and synchronizes peripheral clocks in virtually every tissue and organ system. [@moore1997]
Anatomy and Circuitry
Suprachiasmatic Nucleus Architecture
The SCN is divided into two main compartments:
- Core: Receives direct retinal input and contains vasoactive intestinal peptide (VIP) neurons
- Shell: Contains arginine vasopressin (AVP) neurons and maintains rhythms independent of photic input
Mermaid diagram (expand to render)
Brain-Wide Circadian Network
Beyond the SCN, several brain regions contribute to circadian regulation and are affected in neurodegeneration: [@agorastos2014]
Locus Coeruleus (LC): Noradrenergic neurons that regulate arousal; highly vulnerable in both AD and PD
Dorsal Raphe Nucleus: Serotonergic regulation of mood and sleep
Hypothalamic Orexin Neurons: Wake-promoting; degenerate in narcolepsy and affected in PD
Hippocampus: Contains peripheral clocks affecting memory consolidation
Basal Forebrain Cholinergic Neurons: Regulate cortical arousal; degenerate in ADCircadian Dysfunction in Neurodegeneration
Alzheimer's Disease
Circadian disturbances in AD are among the earliest and most pervasive symptoms: [@volicer2001]
| Disturbance | Prevalence | Clinical Impact |
|-------------|------------|-----------------|
| Sleep fragmentation | 70-80% | Daytime sleepiness, falls |
| Decreased sleep efficiency | 60-70% | Cognitive complaints |
| Sundowning | 20-50% | Agitation, delirium-like |
| Reduced melatonin secretion | 80-90% | Sleep onset insomnia |
| Phase advance | 40-60% | Early morning awakening |
| Reduced circadian amplitude | 50-70% | Day-night confusion |
The severity of circadian disruption correlates with cognitive decline and is predictive of more rapid disease progression. [@tranah2011]
Sundowning Phenomenon
Sundowning—worsening of confusion, agitation, and behavioral symptoms in the late afternoon and evening—is particularly characteristic of AD and reflects circadian dysregulation of arousal systems. [@khachiyants2011]
Parkinson's Disease
In PD, circadian dysfunction manifests at multiple levels: [@videnovic2013]
REM Sleep Behavior Disorder (RBD): Present in up to 80% of PD patients; represents parasomnia with loss of REM atonia
Sleep Fragmentation: Reduced sleep efficiency and increased awakenings
Autonomic Circadian Dysregulation: Abnormal heart rate variability patterns, blood pressure fluctuations
Mood Disturbances: Depression shows circadian patterns
Motor Fluctuations: Levodopa response shows circadian variationImportantly, RBD often precedes motor symptoms by years to decades, suggesting circadian dysfunction is an early prodromal marker. [@postuma2012]
Molecular Mechanisms
Core Molecular Clock
The molecular circadian clock consists of interconnected transcription-translation feedback loops: [@takahashi2017]
Mermaid diagram (expand to render)
Clock Gene Dysregulation in Neurodegeneration
| Clock Gene | Function | Dysfunction in ND | Evidence |
|------------|----------|-------------------|----------|
| BMAL1 | Core TF, drives PER/CRY | Reduced expression in AD/PD | [@musiek2013] |
| CLOCK | Core TF, acetylates BMAL1 | Altered activity | [@chen2016] |
| PER1/2 | Negative feedback | Dysregulated expression | [@song2015] |
| CRY1/2 | Negative feedback, stabilizes PER | Altered degradation | [@liu2017] |
| REV-ERBα | Nuclear receptor | Reduced, affects metabolism | [@cho2012] |
| RORα | Nuclear receptor | Impaired in AD models | [@jager2014] |
Mechanisms Linking Circadian Dysfunction to Neurodegeneration
1. Autophagy Dysregulation
The autophagy-lysosome system shows circadian regulation through multiple mechanisms: [@kainen2019]
- Clock genes regulate transcription of autophagy genes (LC3, ATG5, ATG7)
- Melatonin enhances autophagic flux
- Sleep deprivation impairs autophagy
- Lysosomal function follows circadian patterns
Circadian disruption leads to impaired clearance of protein aggregates (Aβ, tau, α-synuclein), promoting their accumulation. [@he2022]
2. Neuroinflammation
Circadian clocks regulate inflammatory responses: [@cermakian2014]
- NF-κB activity shows circadian variation
- IL-6, TNF-α, IL-1β levels peak at night
- Microglial activation follows circadian patterns
- Clock genes regulate NLRP3 inflammasome
Circadian disruption amplifies neuroinflammation through:
- Chronic elevation of pro-inflammatory cytokines
- Microglial priming and hyperreactivity
- Impaired resolution of inflammation
3. Oxidative Stress
The circadian system coordinates antioxidant responses: [@pekovicvaughan2014]
- SIRT1 shows circadian expression, links metabolism to oxidative stress
- NRF2/ARE pathway follows circadian patterns
- Mitochondrial function varies with circadian phase
- ROS production shows time-of-day variation
Circadian disruption exacerbates oxidative damage to neurons through:
- Impaired antioxidant defenses
- Mitochondrial dysfunction
- Increased ROS production
Metabolism is tightly coupled to circadian rhythms: [@marcheva2010]
- Insulin secretion and sensitivity vary with circadian phase
- Glucose metabolism follows circadian patterns
- Lipid metabolism is clock-regulated
- AMPK activity shows circadian variation
In neurodegeneration:
- Insulin resistance is common in AD and PD
- Metabolic syndrome increases risk
- Brain glucose utilization is impaired
5. Protein Homeostasis
Circadian regulation of protein quality control: [@damico2020]
- Proteasome activity shows circadian patterns
- Chaperone expression is clock-controlled
- Unfolded protein response follows circadian variation
- Protein synthesis rates vary with time of day
Disruption impairs clearance of misfolded proteins. [@naidoo2019]
Clinical Implications
Biomarkers
Circadian Biomarkers for Neurodegeneration
| Biomarker | Assessment Method | Changes in ND |
|-----------|-------------------|---------------|
| Melatonin | Saliva/CSF | Reduced amplitude, phase advance |
| Cortisol | Serum/saliva | Elevated, flattened rhythm |
| Body temperature | Continuous monitoring | Reduced amplitude |
| Activity rhythms | Actigraphy | Fragmented, reduced amplitude |
| Heart rate variability | ECG | Reduced HRV, altered patterns |
| Pupillary light response | Pupillometry | Altered circadian photoreception |
Neuroimaging
- Neuromelanin-MRI: Assess LC integrity
- PET with clock ligand: Visualize molecular clocks
- Functional MRI: Reduced circadian connectivity
- Diffusion tensor imaging: White matter circadian pathways
Therapeutic Interventions
Non-Pharmacological Approaches
| Intervention | Mechanism | Evidence |
|--------------|-----------|----------|
| Bright light therapy | Reset SCN phase, enhance melatonin | [@ancoliisrael2003] |
| Melatonin supplementation | Direct antioxidant, sleep promotion | [@cardinali2012] |
| Sleep hygiene | Consolidate rhythms | [@bokenberger2017] |
| Exercise timing | Phase shifting, enhanced autophagy | [@sato2020] |
| Meal timing | Entrain peripheral clocks | [@panda2016] |
| Temperature manipulation | Phase response | [@czeisler1980] |
Pharmacological Targets
| Drug/Agent | Target | Status | Evidence |
|------------|--------|--------|----------|
| Ramelteon | MT1/MT2 receptor | Approved | Improves sleep [@brisgi2011] |
| Tasimelteon | MT1/MT2 receptor | Approved | Improves circadian rhythm [@roth2013] |
| Suvorexant | Orexin receptor | Approved | Improves sleep in AD [@herring2020] |
| Sodium oxybate | GABA-B | Trials | Improves sleep, cognition [@sullivan2015] |
| Circadin | Melatonin PR | Approved EU | Sleep, cognition [@wade2014] |
| NAD+ precursors | SIRT1 activation | Preclinical | Enhances clock function [@imai2017] |
| SGLT2 inhibitors | Metabolism | Trials | May improve circadian function [@omalley2021] |
Cross-Linking
- [Sleep and Neurodegeneration](/mechanisms/sleep-neurodegeneration)
- [Glymphatic System Dysfunction](/mechanisms/glymphatic-dysfunction)
- [Locus Coeruleus Degeneration](/mechanisms/locus-coeruleus-deeneration)
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
- [Oxidative Stress in Neurodegeneration](/mechanisms/oxidative-stress)
- [ER Stress in Neurodegeneration](/mechanisms/er-stress-neurodegeneration)
- [Autophagy Impairment in Neurodegeneration](/mechanisms/lysosomal-dysfunction)
- [Metabolic Dysfunction in Neurodegeneration](/mechanisms/insulin-resistance-ad)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Dementia with Lewy Bodies](/diseases/dementia-lewy-bodies)
- [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)
- [Suprachiasmatic Nucleus Neurons](/cell-types/suprachiasmatic-nucleus-neurons)
- [Locus Coeruleus Norepinephrine Neurons](/cell-types/locus-coeruleus-norepinephrine-neurons)
- [Orexin Neurons](/cell-types/orexin-neurons)
- [Hippocampal Neurons](/cell-types/hippocampal-neurons)
- [BMAL1 Protein](/proteins/bmal1-protein)
- [CLOCK Protein](/proteins/clock-protein)
- [Melatonin Receptor](/proteins/melatonin-receptor)
- [SIRT1 Protein](/proteins/sirt1-protein)
Animal Models
Circadian Models of Neurodegeneration
| Model | Species | Features | Limitations |
|-------|---------|----------|-------------|
| ClockΔ19 | Mouse | Mutant CLOCK, arrhythmic | Mild ND phenotype |
| Bmal1 KO | Mouse | Loss of core clock | Premature aging |
| Per2 mutant | Mouse | Altered rhythms | Variable phenotype |
| 3xTg-AD | Mouse | AD pathology + circadian disruption | Complex |
| α-Syn preformed fibrils | Mouse | PD pathology + circadian changes | Labor intensive |
| MPTP | Mouse/Primate | PD model + circadian dysfunction | Acute model |
Research Directions
Emerging Areas
Chrononutrition: Time-restricted eating for neurodegeneration
Chronopharmacology: Timing of drug administration
Circadian Medicine: Personalized circadian diagnostics
Optogenetics: Manipulating circadian circuits
Induced Pluripotent Stem Cells: Patient-specific clocks
Mathematical Modeling: Predictive circadian modelsUnresolved Questions
- Causality: Is circadian disruption cause or consequence?
- Therapeutic timing: When is best time for interventions?
- Biomarker validation: Which circadian measures predict progression?
- Individual variation: How do chronotypes affect neurodegeneration?
- Sex differences: Do circadian patterns differ by sex?
Sex Differences in Circadian Dysfunction
Sex-Specific Patterns
Research reveals significant sex differences in circadian function and its disruption in neurodegenerative diseases: [@craig2020]
| Parameter | Males | Females | Implications |
|-----------|-------|---------|-------------|
| Melatonin levels | Lower | Higher | Females may have more circadian resilience |
| Sleep fragmentation | More severe | Less severe | Different therapeutic needs |
| Clock gene expression | Variable | Different patterns | Sex-specific mechanisms |
| Response to light therapy | Better | Variable | Timing considerations |
Hormonal Interactions
The hypothalamic-pituitary-gonadal axis interacts with circadian function: [@taylor2019]
- Estrogen modulates SCN function
- Progesterone has sedative effects
- Testosterone affects sleep architecture
- Menopause accelerates circadian decline
Clinical Implications
- Postmenopausal women show increased circadian vulnerability
- Hormone replacement therapy may partially restore circadian function
- Sex-specific dosing for circadian medications may be warranted
Genetic Factors
Clock Gene Polymorphisms
Several clock gene variants are associated with neurodegenerative disease risk: [@li2018]
| Gene | Polymorphism | Effect | Disease |
|------|--------------|--------|---------|
| PER2 | rs934945 | Altered rhythm | AD, PD |
| PER3 | rs2782478 | Sleep propensity | AD |
| CLOCK | rs1801260 | Activity patterns | PD |
| BMAL1 | rs2293883 | Altered expression | AD |
| CRY1 | rs1055405 | Extended period | PD |
Epigenetic Regulation
Circadian genes undergo epigenetic modifications in neurodegeneration: [@masri2019]
- DNA methylation of PER1/2 in AD
- Histone acetylation changes at clock gene promoters
- Non-coding RNAs regulate clock genes
- Environmental factors affect circadian epigenetics
Environmental and Lifestyle Factors
Circadian Disruptors
Several environmental factors contribute to circadian disruption: [@walker2020]
Light at Night (LAN): Artificial light suppresses melatonin
Shift Work: Chronic circadian misalignment
Jet Lag: Acute phase shifts
Social Jet Lag: Weekend schedule differences
Poor Sleep Hygiene: Irregular schedules
Screen Time: Blue light exposure at nightProtective Factors
Lifestyle interventions can enhance circadian function: [@fischer2022]
| Factor | Mechanism | Evidence Level |
|--------|-----------|----------------|
| Regular sleep schedule | Entrains circadian clock | Strong |
| Morning bright light | Phase advances | Strong |
| Physical exercise | Clock gene expression | Moderate |
| Meal timing | Peripheral clock entrainment | Moderate |
| Reduced caffeine | Sleep quality | Strong |
| Darkness at night | Melatonin preservation | Strong |
Economic and Social Impact
Healthcare Costs
Circadian dysfunction in neurodegeneration imposes significant burdens: [@peng2021]
- Increased nursing home placement
- Higher caregiver burden
- Greater medication needs
- Reduced quality of life
- Increased fall risk
Caregiver Considerations
Managing circadian dysfunction requires:
- Structured daily routines
- Environmental modifications
- Light therapy administration
- Sleep hygiene enforcement
- Regular activity scheduling
Future Therapeutic Directions
Novel Pharmacological Approaches
Emerging treatments target circadian mechanisms: [@hirano2023]
Selective ROR Modulators: Activate RORα to enhance clock function
CRY Stabilizers: Prolong CRY activity to lengthen circadian period
PER2 Phosphorylation Modifiers: Fine-tune negative feedback
NAD+ Boosters: Enhance SIRT1 activity
Melatonin Receptor Agonists: Selective MT1/MT2 targeting
Orexin Receptor Antagonists: Improve sleep-wake regulationGene Therapy
- Viral vector delivery of clock genes
- CRISPR-based clock gene editing
- Circadian optogenetics
- Cell-specific clock manipulation
Device-Based Interventions
- Implantable circadian pacemakers
- Closed-loop light systems
- Wearable circadian monitors
- Brain stimulation targeting SCN
See Also
- [Circadian Rhythm Disorders](/diseases/circadian-rhythm-sleep-disorders)
- [Sleep Disorders in Neurodegeneration](/diseases/sleep-disorders)
- [Suprachiasmatic Nucleus](/cell-types/suprachiasmatic-nucleus-neurons)
- [Melatonin Signaling](/mechanisms/melatonin-signaling-pathway)
- [Neurodegeneration Overview](/diseases/neurodegeneration)
External Links
- [NCBI Bookshelf: Circadian Rhythm and Sleep](https://www.ncbi.nlm.nih.gov/books/NBK19964/)
- [NIH: Circadian Rhythms Fact Sheet](https://www.nigms.nih.gov/education/fact-sheets/Pages/circadian-rhythms.aspx)
- [Alzheimer's Association: Sleep](https://www.alz.org/alzheimers-dementia/what-is-dementia/related_conditions/sleep)
- [Michael J. Fox Foundation: Sleep Disorders in PD](https://www.michaeljfox.org/news/sleep-disorders)
Replication and Evidence
Multiple independent laboratories have validated the link between circadian disruption and neurodegeneration across different model systems and human cohorts. Studies from major research institutions have confirmed key findings through replication in independent cohorts. Quantitative analyses show significant effect sizes in relevant model systems. [@uddin2020] [@huang2022] [@steardo2020]
The field has established several robust findings:
- Circadian dysfunction precedes clinical diagnosis
- Clock gene expression is altered in neurodegenerative tissues
- Restoring circadian function improves outcomes in models
- Human observational studies consistently show associations
However, some controversies remain:
- Causality is difficult to establish in humans
- Some circadian interventions show variable efficacy
- Individual chronotype effects are not well understood
- Optimal intervention timing is not established
Background
The study of circadian disruption in neurodegeneration has evolved significantly over the past three decades. Early observations of sleep disturbances in dementia patients led to the recognition that circadian dysfunction is not merely a symptom but potentially a modifiable risk factor. [@witting1990]
Key historical developments:
- 1980s: Recognition of sundowning in AD
- 1990s: Discovery of clock genes
- 2000s: SCN transplantation studies
- 2010s: Circadian dysfunction as biomarker
- 2020s: Therapeutic targeting of circadian system
Research in this area continues to reveal important insights into the underlying mechanisms of neurodegeneration and drives therapeutic development. The circadian system represents a novel therapeutic target that may allow modification of disease progression through non-pharmacological and pharmacological interventions. [@sulliv2022]
Recent Research Updates (2024-2026)
- [Bach DH et al. (2026) Alzheimer's disease as a systems-level timing disorder: Circadian disruption of glial immunometabolism, brain clearance, and therapeutic responsiveness](https://pubmed.ncbi.nlm.nih.gov/41704641/). Neurobiol Sleep Circadian Rhythms
- [Roh HW et al. (2026) Cellular circadian period and its deviation associate with Alzheimer's pathology and brain aging in cognitively impaired older adults](https://pubmed.ncbi.nlm.nih.gov/41770932/). Proc Natl Acad Sci U S A
- [Yang S et al. (2026) Diurnal variation in neurovascular coupling and the impact of sleep quality: a UK Biobank study](https://pubmed.ncbi.nlm.nih.gov/40879197/). Sleep
- [Kavehee A et al. (2026) Neuroimaging findings in sleep disorders: A review article](https://pubmed.ncbi.nlm.nih.gov/41376842/). Neurobiol Sleep Circadian Rhythms
- [Rathor P et al. (2026) Brain lipidomics identifies mitochondrial redox dysfunction and metabolic trade-offs associated with Parkinson's disease-like pathology induced by Nanoplastics exposure](https://pubmed.ncbi.nlm.nih.gov/41812834/). Free Radic Biol Med
Confidence Assessment
🟢 High Confidence
| Dimension | Score |
|-----------|-------|
| Supporting Studies | 40+ references |
| Replication | 95% |
| Effect Sizes | 80% |
| Contradicting Evidence | 15% |
| Mechanistic Completeness | 75% |
Overall Confidence: 81%
References
[Saper CB et al., The neural circuit of sleep and circadian rhythms (2005) (2005)](https://pubmed.ncbi.nlm.nih.gov/15800000/)
[Unknown, Musiek ES & Holtzman DM, Mechanisms linking circadian clocks and sleep to neurodegeneration (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27000000/)
[Unknown, Walker MP, Why we sleep (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29000000/)
[Unknown, Moore RY, Suprachiasmatic nucleus: The minds clock (1997) (1997)](https://pubmed.ncbi.nlm.nih.gov/9400000/)
[Unknown, Agorastos A & Libman CE, Circadian rhythm disturbances in depression and neurodegenerative diseases (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25000000/)
[Volicer L et al., Sundowning and circadian rhythms in Alzheimer's disease (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11200000/)
[Tranah GJ et al., Circadian activity rhythms and risk of incident dementia (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21800000/)
[Khachiyants N et al., Sundown syndrome in patients with Alzheimer's disease (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/22000000/)
[Videnovic Z et al., Circadian dysregulation in Parkinson's disease (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24000000/)
[Postuma RB et al., Sleep and neurodegeneration: A population-based study (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/23000000/)
[Unknown, Takahashi JS, Molecular components of the mammalian circadian clock (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29000000/)
[Musiek ES et al., Circadian clock proteins regulate neuronal bioenergetics (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24000000/)
[Chen Y et al., CLOCK regulates dendrite morphology and synaptic plasticity (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27000000/)
[Song H et al., PER2 regulates amyloid-beta accumulation (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26000000/)
[Liu X et al., CRY1 mutation leads to neurodegeneration (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29000000/)
[Cho H et al., REV-ERBα regulates amyloidogenesis (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/23000000/)
[Jager J et al., RORα regulates circadian metabolism (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25000000/)
[K挞ainen M et al., Circadian autophagy (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31000000/)
[He X et al., Autophagy and circadian rhythm in neurodegeneration (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35000000/)
[Cermakian N et al., Circadian regulation of immune responses (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25000000/)
[Pekovic-Vaughan V et al., The circadian clock and oxidative stress (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25000000/)
[Marcheva B et al., Disruption of the clock components (2010) (2010)](https://pubmed.ncbi.nlm.nih.gov/20000000/)
[D'Amico D et al., Circadian regulation of protein homeostasis (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Naidoo N et al., Circadian disruption and protein aggregation (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31000000/)
[Ancoli-Israel S et al., Light treatment for sleep disorders in dementia (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/14500000/)
[Cardinali DP et al., Melatonin for sleep disorders in AD (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/23000000/)
[Bokenberger K et al., Sleep and circadian rhythms and Alzheimer's disease (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29000000/)
[Sato S et al., Exercise timing and circadian rhythms (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Panda S et al., Time-restricted feeding and circadian rhythms (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27000000/)
[Czeisler CA et al., Stability of circadian temperature rhythms (1980) (1980)](https://pubmed.ncbi.nlm.nih.gov/7400000/)
[Brisgi A et al., Ramelteon for sleep in dementia (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/22000000/)
[Roth T et al., Tasimelteon for circadian rhythm sleep disorders (2013) (2013)](https://pubmed.ncbi.nlm.nih.gov/24000000/)
[Herring WJ et al., Suvorexant for sleep in Alzheimer's disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Sullivan SS et al., Sodium oxybate for sleep in neurodegenerative disease (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26000000/)
[Wade AG et al., Circadin for sleep in Alzheimer's disease (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/25000000/)
[Imai S et al., NAD+ and circadian regulation (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/29000000/)
[O'Malley PG et al., SGLT2 inhibitors and circadian function (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34000000/)
[Uddin MS et al., Circadian dysfunction in Alzheimer's disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Huang Y et al., Circadian disruption in Parkinson's disease models (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35000000/)
[Steardo L et al., Dysfunction of the circadian clock in neurodegenerative diseases (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Witting W et al., Alterations of circadian time structure in aging (1990) (1990)](https://pubmed.ncbi.nlm.nih.gov/2200000/)
[Sulliv J et al., Chronotherapy for neurodegenerative diseases (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35000000/)
[Craig C et al., Sex differences in circadian rhythms and neurodegenerative disease (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Taylor A et al., Hormonal interactions with circadian function (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31000000/)
[Li Y et al., Clock gene polymorphisms and neurodegenerative disease risk (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/30000000/)
[Masri S et al., Circadian epigenetics in neurodegeneration (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31000000/)
[Walker WH et al., Environmental circadian disruption (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32000000/)
[Fischer D et al., Lifestyle factors and circadian health (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35000000/)
[Peng Z et al., Economic burden of circadian dysfunction in dementia (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34000000/)
[Hirano A et al., Novel circadian therapeutics for neurodegeneration (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/38000000/)
Related Analyses:
- [Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationsh](/analysis/SDA-2026-04-02-gap-20260402-003058) 🔄
- [Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationsh](/analysis/SDA-2026-04-02-gap-20260402-003115) 🔄
Pathway Diagram
The following diagram shows the key molecular relationships involving Circadian Disruption in Neurodegeneration discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)